Q3 2025 Mentice AB Earnings Call Transcript
Key Points
- Mentice AB (FRA:MN2) reported a strong performance in the third quarter with net sales of SEK71 million, marking a 22% increase year over year.
- The company achieved an organic growth of 30%, driven primarily by the medical device industry in North America and the EEA region.
- The EBITDA margin improved to 10.7%, reflecting the positive impact of efficiency measures and strategic cost reductions.
- Mentice AB successfully completed a rights issue, raising approximately SEK32 million, which was oversubscribed, indicating strong investor confidence.
- The launch of a portable virtual simulation system was well received in the market, particularly by large medical device industry companies, opening new market opportunities.
- Order intake for the third quarter was slightly down by 2% year over year, affected by timing issues with two large orders moving to the fourth quarter.
- The healthcare segment showed weak performance due to budget constraints in hospitals, particularly in North America and Europe.
- The APEC region remained flat, with China being a challenging market for Mentice AB to operate in.
- Operational cash flow was negative at almost SEK11 million, primarily due to changes in working capital.
- The annual recurring revenue showed stable development but did not exhibit significant growth, partly due to the subscription-based model in the healthcare segment.
Good morning everyone. My name is Richard Engberg, and I am an equity research analyst here at D&B Carnegie. With me, I have Frans Venker, CEO of Mentice, and Ulrika Voksepp, CFO of Mentice, to present the third quarter. So, the scene is yours. Welcome.
Thank you, Richard. So, thank you for, having us here. we are proud to share the third quarter results. I am here together, of course, with Ulrika Drotz Voksepp, our CFO. And so, we're going to present, not only the highlights and the overview, but also the financial results as also some concluding remarks and also question-and-answers afterwards.
If we look at the third quarter, actually we see quite a strong performance, and it's really our strategic actions are starting to yield results. As we did quite a change also in reduction of operating expenses during the third quarter executed in the third quarter, and so that is also really driving AI and bearing the fruits that we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
